Welcome
Support Centre
22 May 2012 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ ...Back to search results ] [ Print-friendly version ]
Individual Risk Awareness Intervention in Stroke
ISRCTN ISRCTN67999605
ClinicalTrials.gov identifier
Public title Individual Risk Awareness Intervention in Stroke
Scientific title To improve adherence to secondary prevention strategies in a high risk stroke population: a randomised controlled trial
Acronym IRAIS
Serial number at source SLAJ2002
Study hypothesis Improving patients perception of their risk of secondary stroke and heart disease at the time of their first event may improve the likelihood of adherence to secondary prevention strategies such as medication taking and lifestyle modification.
Lay summary
Ethics approval East London Research Ethics Committee approved on the 9th April 2010
Study design Randomised controlled trial
Countries of recruitment United Kingdom
Disease/condition/study domain Stroke
Participants - inclusion criteria 1. Diagnosis of any stroke
2. Aged 18+ years, either sex
3. Cognitively intact in order to understand future consequences of actions to reduce risk
4. Discharge Stroke Scale score of up to and over 40
Participants - exclusion criteria Patients unlikely to survive or be able to attend for the 3 month follow-up consultation
Anticipated start date 01/05/2010
Anticipated end date 01/06/2010
Status of trial Completed
Patient information material Not available in web format, please use the contact details below to request a patient information sheet
Target number of participants 238
Interventions Total participation in the trial for both arms is 3 months or until they have been seen in follow-up once. Both arms will complete a questionnaire collecting demographic information, physiological factors and questions relating to awareness of risk and personal stroke knowledge. The intervention arm receives a 1:1 session for approximately 20 minutes which includes a personalised risk score % for secondary stroke. The control arm receives usual routine practice which involves a 1:1 session with a clinical nurse specialist providing information on stroke.
Primary outcome measure(s) 1. Another stroke event in 3 months
2. Evidence of adherence to secondary prevention lifestyle modifications at 3 month follow-up through patient self reporting and physiological testing in the intervention arm compared to the control arm of the randomised controlled trial
Secondary outcome measure(s) Risk score reduction through lifestyle modification at 3 month follow-up
Sources of funding Imperial College Healthcare NHS Trust (UK) - Hammersmith Hospitals Trustees Research Committee Award
Trial website
Publications
Contact name Miss  Julia  Slark
  Address Room 15, Lab Block 11E
Charing Cross Hospital
Hammersmith
  City/town London
  Zip/Postcode W6 8RF
  Country United Kingdom
  Tel +44 (0)20 3313 0677
  Email j.slark@imperial.ac.uk
Sponsor Imperial College London (UK)
  Address c/o Ms Michelle Quaye
Research Governance Manager
  City/town London
  Zip/Postcode W6 8RF
  Country United Kingdom
  Sponsor website: http://www3.imperial.ac.uk/
Date applied 05/08/2010
Last edited 13/10/2010
Date ISRCTN assigned 13/10/2010
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2012 ISRCTN unless otherwise stated.


BioMed Central